Viewing Study NCT06199232


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2026-02-21 @ 6:44 PM
Study NCT ID: NCT06199232
Status: RECRUITING
Last Update Posted: 2024-12-04
First Post: 2023-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed from Standard Systemic Treatment
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module